These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36573349)
1. Astrocytic aryl hydrocarbon receptor mediates chronic kidney disease-associated mental disorders involving GLT1 hypofunction and neuronal activity enhancement in the mouse brain. Huang YJ; Hung CC; Hsu PC; Lee PY; Tsai YA; Hsin YC; Lee XT; Chou CC; Chen ML; Tarng DC; Lee YH Glia; 2023 Apr; 71(4):1057-1080. PubMed ID: 36573349 [TBL] [Abstract][Full Text] [Related]
2. Uremic toxin indoxyl 3-sulfate regulates the differentiation of Th2 but not of Th1 cells to lessen allergic asthma. Hwang YJ; Yun MO; Jeong KT; Park JH Toxicol Lett; 2014 Feb; 225(1):130-8. PubMed ID: 24291743 [TBL] [Abstract][Full Text] [Related]
3. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Schroeder JC; Dinatale BC; Murray IA; Flaveny CA; Liu Q; Laurenzana EM; Lin JM; Strom SC; Omiecinski CJ; Amin S; Perdew GH Biochemistry; 2010 Jan; 49(2):393-400. PubMed ID: 20000589 [TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease. Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338 [TBL] [Abstract][Full Text] [Related]
5. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction. Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway. Mo Y; Hu D; Yu W; Ji C; Li Y; Liu X; Lu Z J Ethnopharmacol; 2023 May; 308():116244. PubMed ID: 36764562 [TBL] [Abstract][Full Text] [Related]
7. Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease. Sun N; Zhang Y; Ding L; An X; Bai F; Yang Y; Yu K; Fan J; Liu L; Yang H; Yang X J Mol Med (Berl); 2024 May; 102(5):679-692. PubMed ID: 38453697 [TBL] [Abstract][Full Text] [Related]
8. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis. Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558 [TBL] [Abstract][Full Text] [Related]
9. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease. Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072 [TBL] [Abstract][Full Text] [Related]
10. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease. Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422 [TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease. Kamiński T; Michałowska M; Pawlak D Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):624-632. PubMed ID: 28791957 [TBL] [Abstract][Full Text] [Related]
12. Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease. Palzkill VR; Tan J; Yang Q; Morcos J; Laitano O; Ryan TE Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H44-H60. PubMed ID: 37921663 [TBL] [Abstract][Full Text] [Related]
13. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate. Asai H; Hirata J; Hirano A; Hirai K; Seki S; Watanabe-Akanuma M Am J Physiol Cell Physiol; 2016 Jan; 310(2):C142-50. PubMed ID: 26561638 [TBL] [Abstract][Full Text] [Related]
14. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins. Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D Nephron; 2017; 137(1):1-7. PubMed ID: 28490014 [TBL] [Abstract][Full Text] [Related]
15. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor. Asai H; Hirata J; Watanabe-Akanuma M Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954 [TBL] [Abstract][Full Text] [Related]
16. Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells. Lano G; Laforêt M; Von Kotze C; Perrin J; Addi T; Brunet P; Poitevin S; Burtey S; Dou L Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244284 [TBL] [Abstract][Full Text] [Related]
17. Female AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney Disease. Makhloufi C; Nicolas F; McKay N; Fernandez S; Hache G; Garrigue P; Brunet P; Guillet B; Burtey S; Poitevin S Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260098 [TBL] [Abstract][Full Text] [Related]
18. Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor. Liu WC; Shyu JF; Lim PS; Fang TC; Lu CL; Zheng CM; Hou YC; Wu CC; Lin YF; Lu KC Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429048 [TBL] [Abstract][Full Text] [Related]